Urology Times Journal Urologists in Cancer Care Around the Practice K-Cast Conferences Perspectives in mCRPC

Urology Times JournalUrologists in Cancer CareAround the PracticeK-CastConferencesPerspectives in mCRPC

View More Prostate Cancer Bladder Cancer Kidney Cancer BPH OAB and Incontinence Kidney Stones Sexual Dysfunction Hormone Therapy Next-Generation Imaging

Prostate CancerBladder CancerKidney CancerBPHOAB and IncontinenceKidney StonesSexual DysfunctionHormone TherapyNext-Generation Imaging

Business

View More Health Law & Policy Malpractice Consult Practice Management

Health Law & PolicyMalpractice ConsultPractice Management

News

Clinical

All Clinical Benign Conditions Bladder Cancer BPH Female Urology Genitourinary Cancers Hormone Therapy Kidney Cancer Kidney Stones Men's Health Next-Generation Imaging Pediatrics Prostate Cancer Sexual Dysfunction Urologic Surgery

All ClinicalBenign ConditionsBladder CancerBPHFemale UrologyGenitourinary CancersHormone TherapyKidney CancerKidney StonesMen's HealthNext-Generation ImagingPediatricsProstate CancerSexual DysfunctionUrologic Surgery

Media

Podcasts 'Y'tube K-Cast UTv Videos Around the Practice BPH Videos Medical World News Readout 360 Viewpoints

Podcasts'Y'tubeK-CastUTv VideosAround the PracticeBPH VideosMedical World NewsReadout 360Viewpoints

Conferences

Publications

Urologists in Cancer Care Urology Times Journal

Urologists in Cancer CareUrology Times Journal

Events

Live Events Virtual Events

Live EventsVirtual Events

CME/CE

Resources

Interactive Tools Job Board Sponsored

Interactive ToolsJob BoardSponsored

eNewsletter Print Subscription

eNewsletterPrint Subscription

Advertise
Contact Us
Job Board
Terms and Conditions
Privacy
Do not sell my Personnal Information

Spotlight

Urology Times Journal
Urologists in Cancer Care
Around the Practice
K-Cast
Conferences
Perspectives in mCRPC

ClinicalSee All >

Prostate Cancer
Bladder Cancer
Kidney Cancer
BPH
OAB and Incontinence
Kidney Stones
Sexual Dysfunction
Hormone Therapy
Next-Generation Imaging

BusinessSee All >

Health Law & Policy
Malpractice Consult
Practice Management

Advertise
Contact Us
Job Board
Terms and Conditions
Privacy
Do not sell my Personnal Information

Agent delays bone metastases in men with castration-resistant prostate cancer

October 1, 2012

The RANK ligand inhibitor denosumab (XGEVA) may be able to prevent or at least delay multiple and/or symptomatic bone metastases in men with castration-resistant prostate cancer (CRPC) at high risk of bone metastases.